Clinical Trial Detail

NCT ID NCT02450539
Title A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

lung non-small cell carcinoma

Therapies

Abemaciclib

Docetaxel

Age Groups: adult

No variant requirements are available.